StockData
NEXGEL, Inc. logo

NEXGEL, Inc. (NXGL) income statement

NXGLNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31Also trades as NXGLW
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 16, 2026Score 7/3099% below fair value
$3.12−0.23 (-6.84%)

Close on Nov 20, 2026Market cap $1.52MP/E –Yield –

NEXGEL, Inc. income statement

Ratios

Latest available, balances at Sep 30, 2026

Profitability, TTM

Gross margin
33.4%
Operating margin
-58.6%
Net margin
-54.0%
Return on equity, FY2025
-58.7%

Financial strength

Current ratio
0.46
Debt to equity
0.10
Debt to assets
1.7%
Cash to current liabilities
2.6%

Valuation

P/E ratio
–
Price to sales
0.12
Price to book
0.37
Dividend yield
–

See a number that looks wrong?